Olema Pharmaceuticals, Inc. (OLMA)

26.52 -0.62 (-2.28%) USD  |  NASDAQ  |  Jan 20, 10:11
More

Olema Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for OLMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade
Replimune Group, Inc. Upgrade
Genprex, Inc. Upgrade